Lam Dong Pharmaceutical Joint Stock Company (Ladophar – stock code: LDP) has just approved a plan to privately offer 13.64 million shares at VND 11,000 per share to raise over VND 150 billion. The payment deadline is from August 22 to September 30.
Ladophar intends to use VND 58.51 billion of the raised funds to repay the company’s debts (including bank loans and bond debts); VND 25.75 billion for purchasing machinery and equipment to serve production and business activities; and the remaining VND 65.78 billion will be invested in infrastructure and machinery for the project of building a supercritical CO2 herbal extraction workshop.
The expected buyer list includes Dynamic Investment Vision Fund, which plans to purchase 4.25 million shares to increase its ownership to 16.13% of charter capital, HD Fund Management Joint Stock Company, which plans to buy 4 million shares to raise its ownership to 15.18%, and APC Holdings Joint Stock Company, which is expected to buy 5.39 million shares to increase its ownership to 20.46%.
Lam Dong Pharmaceutical Joint Stock Company approves the plan to privately offer 13.64 million shares
Ladophar has been present in the market since 1982, initially known as Lam Dong Pharmaceutical Union Enterprise. In 2021, Louis Holdings Joint Stock Company became a major shareholder of LDP. In the fourth quarter of 2021, after the participation of key personnel from Louis Holdings in the management, LDP surprisingly reported the highest net profit since its establishment, amounting to over VND 55 billion. Thanks to the improved performance in the fourth quarter, Ladophar erased the accumulated loss of the first nine months and recorded a net profit of VND 39 billion in 2021, compared to a loss of VND 26 billion in the previous year.
In April 2022, Mr. Do Thanh Nhan, Chairman of the Board of Directors of Louis Holdings Joint Stock Company, was arrested for “Manipulating the securities market.” Subsequently, Lam Dong Pharmaceutical Joint Stock Company announced that Mr. Pham Trung Kien would assume the position of Chairman of the Board of Directors from April 19, 2022.
In the first half of 2025, Ladophar recorded revenue of nearly VND 111 billion (up 19% over the same period) and after-tax profit of VND 2.24 billion (up over 22% over the same period). As of June 30, Ladophar still had accumulated losses of over VND 50 billion, equivalent to 38% of charter capital, and outstanding loans of over VND 61 billion, equivalent to 57% of owner’s equity.
The Chairman of Ladophar seeks to offload a significant portion of his holdings as the company’s shares soar to new heights.
Mr. Pham Trung Kien, Chairman of the Board of Directors of Ladophar, a leading pharmaceutical company in Vietnam, has recently filed to sell over 1.08 million shares of the company’s stock, equivalent to 8.1% of its capital. If the transaction is successful, Mr. Kien’s ownership will decrease to 0.7%, and he will no longer be a major shareholder. The sale is intended for portfolio restructuring and will be executed through matched orders and/or put-through transactions between August 29 and September 27.
The Real Estate Rush: Firms Flock to Convert Bonds to Stocks
“The issuance of additional shares will dilute existing shareholders’ interests in the short term, but it is a necessary step for real estate businesses to restructure, alleviate cash flow pressures, and enhance their financial safety margins. This move strikes a balance between the interests of bondholders and the company’s long-term viability.”
Extraordinary General Meeting of Novaland: Approving the Issuance of Over 320 Million Shares to Swap Debt, Priced at VND 15,746 and VND 40,000 per Share
“Following these two issuance options, the total ownership ratio of the major shareholder groups (NovaGroup and Diamond Properties) and Mr. Bui Thanh Nhon’s family is expected to reach 39.59%.”